Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder
A Predict-to-Prescribe Approach to Social Communication Treatment in Chinese Preschool Children With Autism Spectrum Disorder
1 other identifier
interventional
112
1 country
2
Brief Summary
An accumulation of research evidence has pointed to parent-implemented communication treatment as effective in reducing the severity of social communication deficits in preschool children with ASD. Despite even high-quality evidence, real-world translation to clinical practice remains challenging, especially for children from lower-income families, for two reasons. First, the treatment outcome is highly variable despite study-level efficacy data, most likely due to unique child and parent factors that make treatment response uneven across individual children. Second, the cost of intervention with the largest effect sizes remains high due to its one-on-one format. With the overarching goal to reduce cost and to increase treatment effectiveness at the individual-child level, this project will conduct a randomized controlled trial (RCT) to compare the effectiveness of two options for intervention to address two specific objectives. The investigators will first ascertain whether parent-implemented communication treatment taught by a speech therapist in an Individual (one-on-one) format is more effective than treatment taught in a Group format (up to 8 families learning together) at the study level. The Individual format is at least 4 times more expensive than the Group format; its relative treatment effect must be empirically ascertained to justify its cost. The investigators will then evaluate what combinations of parent and child behavioral and neural factors determine which format of intervention is likely to be more effective at the individual-child level. It is likely that not all families require the more costly Individual format of intervention. Machine-learning analytics with cross-validation will be used in constructing predictive models of treatment response, which will increase the likelihood of these models being generalizable to new patients. This study will be among the first examples of fulfilling the promise of Precision Medicine in providing guidance to patients and families with developmental disorders not about whether to receive intervention but which option for intervention to receive in the context of multiple options. This predict-to-prescribe approach of ASD intervention will likely lead to a paradigm shift in clinical practice and ultimately result in lowering the overall cost and increasing the effectiveness of intervention for children with ASD as individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedFirst Posted
Study publicly available on registry
July 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedAugust 23, 2024
August 1, 2024
3.6 years
June 29, 2022
August 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Social Affect at 12 months
Comparing the pre- and post-treatment social affect measured by the Social Affect subscore of Autism Diagnostic Observation Scheduleâ„¢, Second Edition (ADOS-2) between groups. The Social Affect subscore of ADOS-2 ranges from 0 to 20; the higher ADOS-2 scores mean a worse outcome.
Baseline and at 12 months after the beginning of treatment
Secondary Outcomes (5)
Change from Baseline Number of Parent-child Turn-taking at 6 months and 12 months
Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Mean Length of Utterance at 6 months and 12 months
Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Number of Nouns and Verbs at 6 months and 12 months
Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Prosody in terms of loudness variation at 6 months and 12 months
Baseline, at 6 months and at 12 months after the beginning of treatment
Change from Baseline Prosody in terms of fundamental frequency at 6 months and 12 months
Baseline, at 6 months and at 12 months after the beginning of treatment
Study Arms (2)
Group-based Parent-implemented Social Communication Training
EXPERIMENTALA group-based parent-implemented social communication treatment program for up to 8 parents of children with autism spectrum disorder
Individual-based Parent-implemented Social Communication Training
ACTIVE COMPARATORAn individual-based parent-implemented social communication treatment program for a parent of a child with autism spectrum disorder
Interventions
A group-based social communication training for parents of preschoolers with autism spectrum disorder will be taught by a speech therapist online (approximately 25 hours distributed over 6 months), with up to 8 parents in a group.
An individual-based social communication training for parents of preschoolers with autism spectrum disorder will be taught by a speech therapist online in a one-on-one format (approximately 25 hours distributed over 6 months).
Eligibility Criteria
You may qualify if:
- Have a confirmed diagnosis of autism spectrum disorder or was evaluated to have elevated likelihood ("at-risk" or "suspected") by a Clinical Psychologist, Psychiatrist or Pediatrician who recommended continuous surveillance.
- ADOS-2 score in the spectrum range (for Modules 1 \& 2) or mild-to-moderate concern range (for Toddler Module)
You may not qualify if:
- Mullen Scale of Early Learning non-verbal age at or less than 12 months
- Parent who has severe psychological or neurological conditions prohibiting them from conducting the treatment program at home (restricted to only the parent in the program)
- Children with any other severe developmental problems beyond autism spectrum disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The Chinese University of Hong Kong
Shatin, Hong Kong
Castle Peak Hospital
Tuenmen, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Stanley Ho Professor of Cognitive Neuroscience; Director of Brain and Mind Institute
Study Record Dates
First Submitted
June 29, 2022
First Posted
July 13, 2022
Study Start
July 1, 2022
Primary Completion
January 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
August 23, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share